Juniper Pharma to restate results since 2013
October 24, 2016 at 18:03 PM EDT
Oct 24 (Reuters) - Drug developer Juniper Pharmaceuticals Inc said it would have to restate its financial statements since 2013 due to revenue-recognition errors related to a supply agreement with an affiliate of Germany's Merck KGaA .
